Clinical Trial Update: XC8 in the Treatment of Patients With Bronchial Asthma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update for XC8 in patients with asthma, indicating the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• XC8

Snippet

Sponsor: PHARMENTERPRISES LLC | Conditions: Bronchial Asthma | Phase 2 | Status: COMPLETED